Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
A quick guide to reputable sources for index level data, plus tips on choosing datasets and validating their reliability for analysis.
24,978 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
GitLab posted its Q4 FY2026 results after the bell, showing revenue and earnings that set the stage for 2027. Stocks ...
As electric-vehicle charging scales up, ChargePoint's 2026 earnings outlook becomes a key signal for investors. This ...
MercadoLibre fell in February amid margin concerns and tougher competition in LATAM. This article breaks down the for...
UBS lifts H World, Wells Fargo reprises Netflix coverage, and JD.com shares a reduced target as institutional views s...
Serve Robotics beats Q4 revenue estimates, lifts 2026 guidance to roughly 10x 2025 levels, and gains credibility from...
United Airlines faces near term pressure from higher fuel costs, yet the Street remains optimistic with a consensus t...
A viral act of generosity helped a 78-year-old DoorDash driver and his wife retire with dignity. But the story also i...
Ohio is poised to boost its innovation engine. By conforming to the federal R&E immediate cost recovery rules, oh...
A wave of zero-emission school bus mandates is accelerating across several states, putting districts under budget pre...
Amazon launches 1-hour and 3-hour delivery across dozens of U.S. markets, delivering faster options for groceries and...
Ethereum climbs as global tensions weigh on markets, outpacing Bitcoin. ETH rises toward $2,300 as the ETH/BTC ratio ...